Skip to main content
Premium Trial:

Request an Annual Quote

Immunex Collaborates with Bioinformatics Co.


SEATTLE--Immunex here and Digital Gene Technologies, La Jolla, Calif., have announced a five-year research collaboration using Total Gene expression Analysis (TOGA), Digital's proprietary bioinformatics platform, to investigate approaches to the diagnosis and treatment of inflammatory diseases of the gastrointestinal system. Immunex paid Digital $3.5 million on signing and will provide an additional $3 million over the course of the agreement. Also, yearly payments of up to $6.5 million will be made to Digital as molecules are identified as research candidates.

"This program significantly enhances the discovery research programs already underway at Immunex in the field of gastrointestinal biology," stated Doug Williams, the company's senior vice-president and head of discovery research. TOGA is a method of identifying and determining the concentration of nearly all genes active in a sample cell or tissue. "We believe that the TOGA technology will allow us to rapidly identify relevant genes involved in inflammatory processes in the gastrointestinal system," he added.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.